Among patients with type 2 diabetes who start taking insulin, those who attain good glycemic control are less likely to have a major adverse cardiac event (MACE) in the medium term than those who fail to achieve this, a new study suggests. The findings come from the Cardiovascular Risk Evaluation …

The FDA has approved the inhaled human insulin product Afrezza to improve glycemic control in adults with type 1 or type 2 diabetes…. 

An international team of researchers reports that the benefits of insulin therapy for people over the age of 50 may not always outweigh the negatives….

A correlation has been found between glucose levels and persistent organic pollutants…. 

A difference in gut bacteria has been seen in obese and diabetic patients when compared to healthy patients…. 

Women with gestational diabetes experienced a number of benefits when taking supplemental calcium plus vitamin D…. 

According to pilot studies, exposure to complex dietary proteins early in life may increase the risk of beta cell autoimmunity in children who are at risk for type 1 diabetes…. 

Polydeoxyribonucleotide (PDRN), an adenosine A2A receptor agonist, improves wound healing…. 

One in 5 kids with diabetes has an A1C above 10%…. 

Evidence is emerging that diabetic foot ulceration is associated with greater risk of premature death….